Pyxis Oncology, Inc. SEC filings PYXS
Pyxis Oncology, Inc. has 356 filings in SEC EDGAR's recent list, going back to Jul 12, 2019. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 3, 2026 | — |
| DEF 14A | Proxy statement | Oct 21, 2026 | Oct 21, 2026 |
| PRE 14A | Preliminary proxy statement | Oct 9, 2026 | Oct 9, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 9, 2026 | — |
| 4/A | Filing | Oct 9, 2026 | Oct 1, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 5, 2026 | — |
| 4 | Insider transaction | Oct 2, 2026 | Oct 1, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 2, 2026 | — |
| 8-K |
Current report
Material agreement, Other events
|
Oct 1, 2026 | Sep 29, 2026 |
| 424B5 | Prospectus supplement | Oct 1, 2026 | — |
| 424B5 | Prospectus supplement | Sep 29, 2026 | — |
| 424B5 | Prospectus supplement | Sep 29, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 9, 2026 | Sep 9, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 4, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 8, 2026 | Sep 3, 2026 |
| 424B2 | Prospectus | Aug 28, 2026 | — |
| EFFECT | Filing | Aug 27, 2026 | — |
| 4 | Insider transaction | Aug 20, 2026 | Aug 20, 2026 |
| S-3 | Shelf registration | Aug 20, 2026 | — |
| 4 | Insider transaction | Aug 14, 2026 | Aug 12, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 3 | Initial insider ownership | Jul 10, 2026 | Jun 30, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 10, 2026 | — |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jul 2, 2026 | Jun 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 2, 2026 | — |
| 144 | Notice of proposed sale | Jun 30, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2026 | Jun 15, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Apr 30, 2026 |
| 8-K/A |
Amended current report
Officer or director change
|
Apr 30, 2026 | Feb 6, 2026 |
| 4 | Insider transaction | Mar 25, 2026 | Mar 24, 2026 |
| 4 | Insider transaction | Mar 25, 2026 | Mar 24, 2026 |
| 4 | Insider transaction | Mar 25, 2026 | Mar 24, 2026 |
| 4 | Insider transaction | Mar 25, 2026 | Mar 24, 2026 |
| 4 | Insider transaction | Mar 25, 2026 | Mar 24, 2026 |
| 4 | Insider transaction | Mar 25, 2026 | Mar 24, 2026 |
| 4 | Insider transaction | Mar 25, 2026 | Mar 24, 2026 |
| 4 | Insider transaction | Mar 25, 2026 | Mar 24, 2026 |
| 4 | Insider transaction | Mar 25, 2026 | Apr 14, 2025 |
| S-8 | Employee stock plan registration | Mar 23, 2026 | — |
| 10-K | Annual report | Mar 23, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 23, 2026 | Mar 23, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 9, 2026 | — |
| 8-K | Current report | Feb 6, 2026 | Feb 6, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 18, 2025 | Dec 18, 2025 |
| EFFECT | Filing | Dec 9, 2025 | — |
| CORRESP | Letter to the SEC | Dec 8, 2025 | — |
| S-3 | Shelf registration | Nov 26, 2025 | — |
| 10-Q | Quarterly report | Nov 3, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2025 | Nov 3, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 23, 2025 | — |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Other events
|
Aug 4, 2025 | Aug 4, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 17, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Jul 3, 2025 | Jul 1, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 1, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2025 | Jun 18, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 15, 2025 | May 15, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 6, 2025 | — |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Apr 29, 2025 |
| 144 | Notice of proposed sale | Apr 21, 2025 | — |
| 144 | Notice of proposed sale | Apr 17, 2025 | — |
| 144 | Notice of proposed sale | Apr 14, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Apr 2, 2025 | — |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 24, 2025 | Mar 24, 2025 |
| S-8 | Employee stock plan registration | Mar 18, 2025 | — |
| 10-K | Annual report | Mar 18, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Mar 18, 2025 | Mar 18, 2025 |
| 8-K |
Current report
Other events
|
Feb 26, 2025 | Feb 26, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 4, 2025 | — |
| 8-K |
Current report
Other events
|
Feb 4, 2025 | Feb 4, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Dec 23, 2024 | — |
| 4 | Insider transaction | Dec 23, 2024 | Dec 23, 2024 |
| 4 | Insider transaction | Dec 23, 2024 | Dec 23, 2024 |
| 4 | Insider transaction | Dec 23, 2024 | Dec 23, 2024 |
| 8-K |
Current report
Other events
|
Dec 19, 2024 | Dec 19, 2024 |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 16, 2024 | — |
| 4 | Insider transaction | Nov 27, 2024 | Nov 26, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 20, 2024 | Nov 20, 2024 |
| S-8 | Employee stock plan registration | Nov 12, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 6, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Oct 23, 2024 | Oct 23, 2024 |
| DEF 14A | Proxy statement | Sep 25, 2024 | Sep 25, 2024 |
| PRE 14A | Preliminary proxy statement | Sep 13, 2024 | Sep 13, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 10, 2024 |
| 3 | Initial insider ownership | Jun 10, 2024 | Jun 10, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 10, 2024 | Jun 10, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 7, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 11, 2024 |
| 424B2 | Prospectus | Apr 4, 2024 | — |
| EFFECT | Filing | Apr 3, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Apr 3, 2024 | — |
| CORRESP | Letter to the SEC | Apr 1, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 29, 2024 | — |
| 4 | Insider transaction | Mar 28, 2024 | Mar 26, 2024 |
| 4 | Insider transaction | Mar 28, 2024 | Mar 26, 2024 |
| 4 | Insider transaction | Mar 28, 2024 | Mar 26, 2024 |
| 4 | Insider transaction | Mar 28, 2024 | Mar 26, 2024 |
| 4 | Insider transaction | Mar 28, 2024 | Mar 26, 2024 |
| 4 | Insider transaction | Mar 28, 2024 | Mar 26, 2024 |
| 4 | Insider transaction | Mar 28, 2024 | Mar 26, 2024 |
| 4 | Insider transaction | Mar 28, 2024 | Mar 26, 2024 |
| 4 | Insider transaction | Mar 28, 2024 | Mar 26, 2024 |
| S-3 | Shelf registration | Mar 27, 2024 | — |
| 8-K |
Current report
Other events
|
Mar 27, 2024 | Mar 27, 2024 |
| 8-K |
Current report
Other events
|
Mar 27, 2024 | Mar 27, 2024 |
| S-8 | Employee stock plan registration | Mar 22, 2024 | — |
| 10-K | Annual report | Mar 21, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 21, 2024 | Mar 21, 2024 |
| 4 | Insider transaction | Mar 13, 2024 | Mar 12, 2024 |
| 3 | Initial insider ownership | Mar 13, 2024 | Mar 12, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 13, 2024 | Mar 12, 2024 |
| SC 13G | Ownership over 5% (passive) | Mar 8, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Feb 28, 2024 | Feb 26, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jan 26, 2024 | — |
| 4 | Insider transaction | Dec 29, 2023 | Dec 29, 2023 |
| 3 | Initial insider ownership | Dec 6, 2023 | Nov 27, 2023 |
| 4 | Insider transaction | Nov 30, 2023 | Nov 29, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 28, 2023 | Nov 27, 2023 |
| 4 | Insider transaction | Nov 17, 2023 | Nov 15, 2023 |
| 10-Q | Quarterly report | Nov 7, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2023 | Nov 7, 2023 |
| 8-K/A | Amended current report | Oct 27, 2023 | Aug 23, 2023 |
| 4 | Insider transaction | Sep 28, 2023 | Sep 28, 2023 |
| 4 | Insider transaction | Sep 27, 2023 | Sep 27, 2023 |
| 4 | Insider transaction | Sep 27, 2023 | Sep 27, 2023 |
| 4 | Insider transaction | Sep 26, 2023 | Sep 22, 2023 |
| 4 | Insider transaction | Sep 25, 2023 | Sep 25, 2023 |
| 4 | Insider transaction | Sep 25, 2023 | Sep 25, 2023 |
| 4 | Insider transaction | Sep 22, 2023 | Sep 22, 2023 |
| 4 | Insider transaction | Sep 22, 2023 | Sep 22, 2023 |
| 4 | Insider transaction | Sep 18, 2023 | Sep 14, 2023 |
| 144 | Notice of proposed sale | Sep 18, 2023 | — |
| 144 | Notice of proposed sale | Sep 14, 2023 | — |
| 4 | Insider transaction | Sep 13, 2023 | Sep 11, 2023 |
| 144 | Notice of proposed sale | Sep 13, 2023 | — |
| 144 | Notice of proposed sale | Sep 12, 2023 | — |
| 144 | Notice of proposed sale | Sep 11, 2023 | — |
| 4 | Insider transaction | Sep 8, 2023 | Sep 7, 2023 |
| 4 | Insider transaction | Sep 8, 2023 | Sep 7, 2023 |
| 4 | Insider transaction | Sep 8, 2023 | Sep 7, 2023 |
| UPLOAD | Letter from the SEC | Sep 6, 2023 | — |
| 144 | Notice of proposed sale | Sep 5, 2023 | — |
| CORRESP | Letter to the SEC | Aug 28, 2023 | — |
| 4 | Insider transaction | Aug 25, 2023 | Aug 23, 2023 |
| 3 | Initial insider ownership | Aug 25, 2023 | Aug 23, 2023 |
| EFFECT | Filing | Aug 24, 2023 | — |
| S-8 POS | Form s-8 pos | Aug 23, 2023 | — |
| POS AM | Form pos am | Aug 23, 2023 | — |
| S-8 | Employee stock plan registration | Aug 23, 2023 | — |
| 8-K |
Current report
Acquisition or sale of assets, Officer or director change, Regulation FD disclosure
|
Aug 23, 2023 | Aug 23, 2023 |
| UPLOAD | Letter from the SEC | Aug 16, 2023 | — |
| 144 | Notice of proposed sale | Aug 11, 2023 | — |
| 10-Q | Quarterly report | Aug 11, 2023 | Jun 30, 2023 |
| 425 | Filing | Aug 11, 2023 | — |
| 8-K |
Current report
Results of operations
|
Aug 11, 2023 | Aug 11, 2023 |
| 425 | Filing | Aug 11, 2023 | — |
| 8-K |
Current report
Other events
|
Aug 11, 2023 | Aug 11, 2023 |
| 144 | Notice of proposed sale | Aug 1, 2023 | — |
| 144 | Notice of proposed sale | Jul 31, 2023 | — |
| 144/A | Filing | Jul 28, 2023 | — |
| 144 | Notice of proposed sale | Jul 27, 2023 | — |
| 144 | Notice of proposed sale | Jul 21, 2023 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PYXS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1782223
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.